Related Experiment Videos
Geriatric assessment for oncologists: rationale and future directions
Arti Hurria1, Mark S Lachs, Harvery J Cohen
1Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. hurriaa@mskcc.org
Critical Reviews in Oncology/Hematology
|June 30, 2006
Summary
Developing a geriatric assessment for older cancer patients is crucial for tailoring treatments and predicting outcomes beyond chronological age. This tool aims to optimize cancer care for the aging population.
Area of Science:
- Geriatric Oncology
- Cancer Epidemiology
- Clinical Assessment
Background:
- Cancer disproportionately affects individuals over 65, representing 60% of occurrences and 70% of mortalities.
- There's a growing need to assess the "functional age" of older cancer patients to personalize treatment and predict outcomes.
- Current assessment methods often overlook factors critical for geriatric cancer patients.
Purpose of the Study:
- To formulate a geriatric assessment specifically for older patients with cancer.
- To identify factors beyond chronological age that predict cancer treatment morbidity and mortality.
- To develop a tool that aids in optimizing oncologic care for the elderly population.
Main Methods:
- Selection of assessment measures based on validity, reliability, brevity, and self-administration adaptability.
- Inclusion of essential domains predictive of survival in the geriatric population.
- Focus on a primarily self-administered assessment requiring limited personnel time.
Main Results:
- The proposed geriatric assessment covers key survival-predictive domains for older adults.
- The assessment is designed for self-administration, minimizing healthcare professional burden.
- It aims to identify independent predictors of cancer treatment outcomes in the elderly.
Conclusions:
- A validated geriatric assessment can help stratify older cancer patients by functional status, not just age.
- This tool has the potential to guide personalized treatment decisions and improve patient outcomes.
- Further research will confirm if this assessment identifies factors for developing targeted interventions in geriatric oncology.